Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy? [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
In a nutshell, it looks like a single infusion of VX-880 allowed a dozen diabetes patients to begin producing their own insulin. It worked so well that nearly everyone treated has reduced their reliance on regular insulin injections. In response to good news from the VX-880 program, Wells Fargo analyst Mohit Bansal raised his price target to $555 and maintained an overweight rating. The new target implies a gain of about 19% from recent prices. Is Vertex Pharmaceuticals a good investment right now? Let's weigh its strengths against some of its challenges to find out. Why VX-880 could make Vertex Pharmaceuticals a great investment There are roughly 1.5 million American adults with diagnosed cases of type 1 diabetes. This is the early-onset form of the disease that occurs after a patient's immune system attacks and destroys islet cells in the pancreas. Blood sugar levels spike after a meal, and in healthy folks, islet cells start secreting appropriate amounts of insulin, which
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- 2 Superior Growth Stocks to Buy if You Have $1,000 Right Now [Yahoo! Finance]Yahoo! Finance
- Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 [Yahoo! Finance]Yahoo! Finance
- 2 Healthcare Stocks That Are Screaming Buys in June [Yahoo! Finance]Yahoo! Finance
- Wells Fargo updated its Signature Picks, with Vertex Pharma and AvalonBay as adds [Seeking Alpha]Seeking Alpha
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $545.00 price target on the stock.MarketBeat
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 6/28/24 - Form 4
- 6/27/24 - Form 8-K
- 6/26/24 - Form 144
- VRTX's page on the SEC website